COMPUGROUP MEDSPADR's market value is the price at which a share of COMPUGROUP MEDSPADR trades on a public exchange. It measures the collective expectations of COMPUGROUP MEDSPADR 1 investors about its performance. COMPUGROUP MEDSPADR is trading at 22.00 as of the 11th of January 2025. This is a 4.76% up since the beginning of the trading day. The stock's lowest day price was 21.0. With this module, you can estimate the performance of a buy and hold strategy of COMPUGROUP MEDSPADR 1 and determine expected loss or profit from investing in COMPUGROUP MEDSPADR over a given investment horizon. Check out COMPUGROUP MEDSPADR Correlation, COMPUGROUP MEDSPADR Volatility and COMPUGROUP MEDSPADR Alpha and Beta module to complement your research on COMPUGROUP MEDSPADR.
Please note, there is a significant difference between COMPUGROUP MEDSPADR's value and its price as these two are different measures arrived at by different means. Investors typically determine if COMPUGROUP MEDSPADR is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, COMPUGROUP MEDSPADR's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
COMPUGROUP MEDSPADR 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to COMPUGROUP MEDSPADR's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of COMPUGROUP MEDSPADR.
0.00
12/12/2024
No Change 0.00
0.0
In 30 days
01/11/2025
0.00
If you would invest 0.00 in COMPUGROUP MEDSPADR on December 12, 2024 and sell it all today you would earn a total of 0.00 from holding COMPUGROUP MEDSPADR 1 or generate 0.0% return on investment in COMPUGROUP MEDSPADR over 30 days. COMPUGROUP MEDSPADR is related to or competes with H2O Retailing, Grand Canyon, RETAIL FOOD, Carsales, and EMBARK EDUCATION. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide More
COMPUGROUP MEDSPADR Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure COMPUGROUP MEDSPADR's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess COMPUGROUP MEDSPADR 1 upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for COMPUGROUP MEDSPADR's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as COMPUGROUP MEDSPADR's standard deviation. In reality, there are many statistical measures that can use COMPUGROUP MEDSPADR historical prices to predict the future COMPUGROUP MEDSPADR's volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as COMPUGROUP MEDSPADR. Your research has to be compared to or analyzed against COMPUGROUP MEDSPADR's peers to derive any actionable benefits. When done correctly, COMPUGROUP MEDSPADR's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in COMPUGROUP MEDSPADR.
COMPUGROUP MEDSPADR Backtested Returns
COMPUGROUP MEDSPADR is somewhat reliable given 3 months investment horizon. COMPUGROUP MEDSPADR secures Sharpe Ratio (or Efficiency) of 0.16, which signifies that the company had a 0.16% return per unit of risk over the last 3 months. We were able to interpolate data for thirty different technical indicators, which can help you to evaluate if expected returns of 1.08% are justified by taking the suggested risk. Use COMPUGROUP MEDSPADR mean deviation of 3.25, and Risk Adjusted Performance of 0.114 to evaluate company specific risk that cannot be diversified away. COMPUGROUP MEDSPADR holds a performance score of 12 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 0.11, which signifies not very significant fluctuations relative to the market. As returns on the market increase, COMPUGROUP MEDSPADR's returns are expected to increase less than the market. However, during the bear market, the loss of holding COMPUGROUP MEDSPADR is expected to be smaller as well. Use COMPUGROUP MEDSPADR coefficient of variation, jensen alpha, sortino ratio, as well as the relationship between the standard deviation and total risk alpha , to analyze future returns on COMPUGROUP MEDSPADR.
Auto-correlation
0.03
Virtually no predictability
COMPUGROUP MEDSPADR 1 has virtually no predictability. Overlapping area represents the amount of predictability between COMPUGROUP MEDSPADR time series from 12th of December 2024 to 27th of December 2024 and 27th of December 2024 to 11th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of COMPUGROUP MEDSPADR price movement. The serial correlation of 0.03 indicates that only 3.0% of current COMPUGROUP MEDSPADR price fluctuation can be explain by its past prices.
Correlation Coefficient
0.03
Spearman Rank Test
-0.07
Residual Average
0.0
Price Variance
0.21
COMPUGROUP MEDSPADR lagged returns against current returns
Autocorrelation, which is COMPUGROUP MEDSPADR stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting COMPUGROUP MEDSPADR's stock expected returns. We can calculate the autocorrelation of COMPUGROUP MEDSPADR returns to help us make a trade decision. For example, suppose you find that COMPUGROUP MEDSPADR has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
COMPUGROUP MEDSPADR regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If COMPUGROUP MEDSPADR stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if COMPUGROUP MEDSPADR stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in COMPUGROUP MEDSPADR stock over time.
Current vs Lagged Prices
Timeline
COMPUGROUP MEDSPADR Lagged Returns
When evaluating COMPUGROUP MEDSPADR's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of COMPUGROUP MEDSPADR stock have on its future price. COMPUGROUP MEDSPADR autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, COMPUGROUP MEDSPADR autocorrelation shows the relationship between COMPUGROUP MEDSPADR stock current value and its past values and can show if there is a momentum factor associated with investing in COMPUGROUP MEDSPADR 1.
Other Information on Investing in COMPUGROUP Stock
COMPUGROUP MEDSPADR financial ratios help investors to determine whether COMPUGROUP Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in COMPUGROUP with respect to the benefits of owning COMPUGROUP MEDSPADR security.